Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 97,750 | 91,950 | 84,953 | 87,082 | 80,807 |
| Cost of Goods | 18,003 | 14,401 | 17,412 | 16,729 | 14,970 |
| Gross Profit | 79,747 | 77,549 | 67,541 | 70,353 | 65,837 |
| Operating Expenses | 81,689 | 74,907 | 65,163 | 64,700 | 56,674 |
| Operating Income | -1,939 | 3,043 | 2,790 | 6,382 | 10,133 |
| Interest Expense | 3,008 | 2,635 | 2,429 | 2,719 | 2,880 |
| Other Income | 329 | 171 | 1,426 | 219 | 332 |
| Pre-tax Income | -4,618 | 579 | 1,787 | 3,882 | 7,585 |
| Income Tax | -221,952 | 1,056 | 636 | -830 | 945 |
| Net Income Continuous | 217,334 | -477 | 1,151 | 4,712 | 6,640 |
| Net Income | $217,334 | $-477 | $1,151 | $4,712 | $6,640 |
| EPS Basic Total Ops | 2.13 | 0.00 | 0.01 | 0.05 | 0.07 |
| EPS Basic Continuous Ops | 2.13 | 0.00 | 0.01 | 0.05 | 0.07 |
| EPS Diluted Total Ops | 1.68 | -0.01 | 0.01 | 0.05 | 0.07 |
| EPS Diluted Continuous Ops | 1.66 | 0.00 | 0.01 | 0.05 | 0.07 |
| EBITDA(a) | $6,885 | $10,923 | $9,398 | $12,197 | $15,804 |